P3 Health Partners Income Statement (2021-2026) | PIII

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue (Quarter)
151.42M156.19M217.94M273.54M269.45M248.26M258.21M302.08M329.09M288.35M346.86M388.49M379.16M362.12M370.69M373.23M355.79M345.25M384.81M386.38M
Cost of Revenue (Quarter)
150.38M161.33M244.81M265.82M267.45M254.78M269.18M285.57M302.27M279.22M367.68M382.06M365.17M401.92M410.22M372.04M351.35M369.79M426.06M300.38M
Gross Profit (Quarter)
1.04M-5.14M-26.87M7.72M2.01M-6.52M-10.96M16.51M26.82M9.13M-20.82M6.43M13.99M-39.80M-39.54M1.18M4.44M-24.54M-41.24M86.00M
Operating items
Amortization - Intangibles (Quarter)
21.16M
Research & Development (Quarter)
0.36M0.49M0.86M1.41M1.12M1.71M1.00M0.86M0.65M0.72M0.32M0.41M0.13M0.46M0.18M0.15M0.25M0.34M
Selling, General & Administrative (Quarter)
18.39M20.43M38.60M41.10M37.86M39.72M37.64M27.22M33.06M24.43M27.40M26.61M27.22M31.37M25.00M23.30M22.14M35.88M32.39M
Other Operating Expenses (Quarter)
151.81M163.38M286.25M1,139.13M269.29M753.33M312.25M322.04M288.45M385.97M404.60M383.47M441.76M13.27M386.13M366.47M367.09M0.18M312.76M
Operating Expenses (Quarter)
170.56M184.31M325.71M1,181.64M308.27M794.76M350.89M350.12M322.17M411.12M432.32M410.49M469.11M509.19M411.31M389.91M389.48M538.68M345.15M
Operating Income (Quarter)
-25.97M-28.12M-26.87M-52.17M-912.19M-60.01M-536.55M-48.82M-21.03M-33.82M-64.26M-43.83M-31.33M-106.99M-138.50M-38.09M-34.12M-44.22M-153.87M41.23M
EBIT (Quarter)
-25.97M-28.12M-26.87M-52.17M-912.19M-60.01M-536.55M-48.82M-21.03M-33.82M-64.26M-43.83M-31.33M-106.99M-138.50M-38.09M-34.12M-44.22M-153.87M41.23M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.00M
Other Non Operating Income (Quarter)
-0.01M-0.03M0.21M2.58M0.10M-0.74M0.19M0.21M0.34M0.29M0.45M0.38M0.32M0.58M-2.16M-2.15M-0.08M
Non Operating Income (Quarter)
-3.49M-3.93M-8.62M9.08M-5.32M6.08M-3.34M-6.32M-3.06M-3.08M-3.70M3.53M0.54M14.31M-5.08M-7.56M-25.23M-12.89M-24.31M
Net income details
EBT (Quarter)
-29.46M-32.05M-26.87M-60.79M-903.11M-65.33M-530.47M-52.16M-27.36M-36.88M-67.34M-47.53M-27.81M-106.45M-124.20M-43.17M-41.68M-69.45M-166.75M16.92M
Tax Provisions (Quarter)
1.86M0.29M0.23M0.41M1.77M2.07M0.97M-3.60M4.95M1.07M1.98M0.01M-1.04M1.26M
Profit After Tax (Quarter)
-29.46M-32.05M-26.87M-60.80M-154.35M-11.17M-532.36M-52.40M-9.82M-37.29M-69.08M-49.60M-12.02M-46.51M-129.18M-20.48M-43.66M-31.59M-165.71M15.65M
Income from Non-Controlling Interests (Quarter)
-1.96M-2.80M-27.29M-50.21M-748.76M-54.16M-438.31M-43.25M-17.77M-23.99M-43.65M-30.91M-16.75M-56.34M-70.53M-23.77M-23.30M-37.87M-90.19M8.21M
Income from Continuing Operations (Quarter)
-29.46M-32.05M-26.87M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Consolidated Net Income (Quarter)
-29.46M-32.05M-26.87M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Income towards Parent Company (Quarter)
-29.46M-32.05M-26.87M-60.79M-903.11M-65.33M-532.33M-52.45M-27.58M-37.29M-69.11M-49.61M-28.77M-102.85M-129.15M-44.25M-43.66M-69.46M-165.71M15.65M
Preferred Dividend Payments (Quarter)
9.57M
Net Income towards Common Stockholders (Quarter)
-2.13M
Additional items
EPS (Basic) (Quarter)
-0.63
EPS (Diluted) (Quarter)
-0.63
Shares Outstanding (Quarter)
3.36M
Shares Outstanding (Diluted) (Quarter)
3.36M
Shares Outstanding (Entity) (Quarter)
3.91M
EBITDA (Quarter)
41.23M
Interest Expenses (Quarter)
7.86M
Tax Rate (Quarter)
7.48%